What research findings exist regarding Cerebrolysin in post-stroke neurological and functional rehabilitation?
Adjunct Cerebrolysin associated with better 12-month functional independence. Additional research reports: adding Cerebrolysin associated with improvement in 14-day neurological and daily living ability scores.[1] ↗ [2] ↗
Currently, 3 original studies related to the theme of this page have been selected. The number of studies includes different designs, populations, or preparations, not commercial clinical efficacy ratings. This page is a usage-oriented positive data selection, not a systematic review or dosing recommendation. Historical studies, combination preparations, and special models are all separately indicated.
Comparison of study design and results
Results from different populations, species, materials, or follow-up times cannot be directly combined. The table below is a comparative summary of published data, not new experimental data.
| Literature | Study subjects and design | Observation and discovery | Scope of Explanation |
|---|---|---|---|
| 2026 · PMID 41739286 | Propensity-matched observational cohort of stroke thrombectomy patients | Adjunct Cerebrolysin associated with better 12-month functional independence. | Selective population, no random assignment, residual confounding exists. |
| 2025 · PMID 41010922 | Single-center prospective observation; acute ischemic stroke | Adding Cerebrolysin was associated with improved nerve and daily ability scores at 14 days. | Short follow-up, non-randomized; clinical formulation and the 60mg powder on the website cannot be assumed to be the same. |
| 2025 · PMID 40851188 | Multinational real-world stroke comparison; C-REGS2 | Functional recovery indicators were better at 90 days in patients with moderate acute ischemic stroke. | Observational comparison; cannot be considered a randomized trial. |
References
How should functional follow-up be interpreted for stroke populations after thrombus removal?
Adjunct Cerebrolysin associated with better 12-month functional independence.[1] ↗
Propensity-matched observational cohort of stroke thrombectomy patients
Selective population, no random assignment, residual confounding exists.
View the Article Title and Full Citation＋
Cerebrolysin after Endovascular Thrombectomy in Stroke: 12‑Month Functional Outcomes in a Propensity‑Matched Cohort.
Translational Stroke Research · Volume and issue year 2026
First published 2026-02-25 · PMID 41739286
DOI 10.1007/s12975-026-01414-z
What does the short-term stroke observation of the standard treatment adjuvant protocol indicate?
Adding Cerebrolysin was associated with improved nerve and daily ability scores at 14 days.[2] ↗
Single-center prospective observation; acute ischemic stroke
Short follow-up, non-randomized; clinical formulation and the 60mg powder on the website cannot be assumed to be the same.
View the Article Title and Full Citation＋
Evaluating the Effect of Cerebrolysin as an Adjuvant to Standard Therapy in Patients with Acute Ischemic Stroke: A Prospective Observational Study.
Medicina (Kaunas, Lithuania) · Volume/Issue Year 2025
First published 2025-08-26 · PMID 41010922
DOI 10.3390/medicina61091531
What findings are there in multinational stroke real-world comparisons?
Functional recovery indicators were better at 90 days in patients with moderate acute ischemic stroke.[3] ↗
Multinational real-world stroke comparison; C-REGS2
Observational comparison; cannot be considered a randomized trial.
View the Article Title and Full Citation＋
C-REGS2-A multinational, high-quality comparative effectiveness study of Cerebrolysin in moderate acute ischemic stroke.
International Journal of Stroke: Official Journal of the International Stroke Society · Volume/Issue/Year 2025
First published 2025-08-24 · PMID 40851188
DOI 10.1177/17474930251375439
Common issues and corresponding evidence
What research findings exist regarding Cerebrolysin in post-stroke neurological and functional rehabilitation?＋
Adjunct Cerebrolysin associated with better 12-month functional independence. Additional research reports: adding Cerebrolysin associated with improvement in 14-day neurological and daily living ability scores.[1] ↗ [2] ↗
Can the clinical data of Cerebrolysin in mL match 60mg lyophilized product?＋
cannot be automatically matched. Source, formulation, and activity correspondence information is required; the selected stroke studies also include observational designs, and correlation cannot be directly considered as causal efficacy.[1] ↗ [2] ↗ [3] ↗
Cerebrolysin—these conclusions apply to which study populations?＋
Propensity-matched observational cohort of stroke thrombectomy patients; single-center prospective observation; acute ischemic stroke; multi-country real-world stroke comparison; C-REGS2. Selective population, no random allocation, residual confounding exists.[1] ↗ [2] ↗ [3] ↗
Cerebrolysin
Return to catalog specifications and batch file verification entry.
